The Rise of Generative AI in Hospitals and Pharmaceutical Companies
Revolutionizing Healthcare with AI: Startups Making Headway. Innovation in the healthcare industry is happening at a breakneck pace, and startups using artificial intelligence are leading the charge.
Despite some concerns about accuracy, these startups are quickly making inroads into hospitals and pharmaceutical companies.
One such startup, Abridge AI Inc., based in Pittsburgh, has developed a tool that helps doctors write notes after seeing patients, freeing up valuable time that doctors can spend on patient care.
San Francisco-based Syntegra Inc. has developed a system that uses generative AI to create synthetic patient data for research.
These companies claim to have developed some of the safest and most accurate uses of generative AI in healthcare.
Despite the promise of these technologies, healthcare experts are hesitant to employ generative AI for patient diagnosis or direct patient care.
The technology has been known to “hallucinate” or manufacture a response when it lacks sufficient information.
Nonetheless, the University of Kansas Health System is implementing one of the first widespread applications of generative AI in healthcare.
They are making Abridge’s tool available to over 2,000 physicians and medical staff in the Kansas City area.
Abridge’s platform uses generative AI to provide summaries of medical conversations from audio captured during patient visits, allowing doctors to spend less time taking notes.
This reduction in paperwork obligations is a primary focus for many hospital IT leaders, especially during the pandemic.
UPMC, a healthcare provider based in Pittsburgh, is also increasing its usage of Abridge. As soon as the tool is included in electronic medical records systems like those from Epic Systems Corp. and Cerner Corp., UPMC plans to roll out the Abridge platform for its thousands of medical personnel.
Generative AI is a type of artificial intelligence that can develop content like computer code and digital illustrations, as well as human-like prose.
Technology giants like Salesforce Inc. and Microsoft Corp. have already integrated the technology into their business software, while startups like Abridge and Syntegra are using it to produce synthetic medical data and imitated patient records.
While some experts are skeptical about the accuracy of generative AI applications, others see a bright future ahead.
According to Dr. Bart of UPMC, although the technology is currently just a “fancy toy” for diagnosis, it is likely to improve operational operations in healthcare quickly.
This includes patient flow and scheduling, which have long-needed technological improvements. And who knows one day, generative AI could revolutionize the way people are diagnosed and treated for the disease.